Literature DB >> 26883651

Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?

Pablo D Roitman1, Germán L Farfalli2, Miguel A Ayerza2, D Luis Múscolo2, Federico E Milano3,4, Luis A Aponte-Tinao2.   

Abstract

BACKGROUND: Central chondrosarcoma of bone is graded on a scale of 1 to 3 according to histological criteria. Clinically, these tumors can be divided into low-grade (Grade 1) and high-grade (Grade 2, Grade 3, and dedifferentiated) chondrosarcomas. Although en bloc resection has been the most widely used treatment, it has become generally accepted that in selected patients with low-grade chondrosarcomas of long bones, curettage is safe and effective. This approach requires an accurate preoperative estimation of grade to avoid under- or overtreatment, but prior reports have indicated that both imaging and biopsy do not always give an accurate prediction of grade. QUESTIONS/PURPOSES: (1) What is the concordance of image-guided needle preoperative biopsy and postoperative grading in central (intramedullary) chondrosarcomas of long bones, and how does this compare with the concordance of image-guided needle preoperative biopsy and postoperative grading in central pelvic chondrosarcomas? (2) What is the concordance of preoperative image-guided needle biopsy and postoperative findings in differentiating low-grade from high-grade central chondrosarcomas of long bones, and how does this compare with the concordance in central pelvic chondrosarcomas?
METHODS: Between 1997 and 2014, in our institution, we treated 126 patients for central chondrosarcomas located in long bones and the pelvis. Of these 126 cases, 41 were located in the pelvis and the remaining 85 cases were located in long bones. This study considers 39 (95%) and 40 (47%) of them, respectively. We included all cases in which histological information was complete regarding preoperative and postoperative tumor grading. We excluded all cases with incomplete data sets or nondiagnostic preoperative biopsies. To evaluate the needle biopsy accuracy, we compared the histological tumor grade, obtained from the preoperative biopsy, with the final histological grade obtained from the postoperative surgical specimen. The weighted and nonweighted kappa statistics were used to evaluate the agreement.
RESULTS: Concordance between the preoperative biopsy and the final pathological analysis in terms of histological grade was much higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (83% [33 of 40] versus 36% [14 of 39]; odds ratio, 8, 48). Likewise, the weighted kappa coefficients were higher in long-bone chondrosarcoma than in pelvic chondrosarcoma for the determination of histological grade (0.63; 95% confidence interval [CI], 0.34-0.91 versus 0.12; -0.32 to 0.57; p < 0.001). When categorizing the lesions as low grade or high grade, concordance between the preoperative biopsy and the final pathological analysis was much higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (90% [36 of 40] versus 67% [26 of 39]; odds ratio, 4, 5). Likewise, the weighted kappa coefficients were higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (0.73; 95% CI, 0.51-0.94 versus 0.26; 0.04-0.48; p < 0.001).
CONCLUSIONS: Image-guided needle biopsy, when performed by a specialist radiologist and evaluated by an experienced bone pathologist, is a useful tool in determining the histological grade of long-bone chondrosarcomas allowing identification of true low-grade tumors. The histological grade should be correlated with imaging and the clinical presentation, but under these circumstances, experienced tumor surgeons may use this information in planning surgical treatment. The same appears not to be true for pelvic lesions, in which histological grade established by needle biopsy should be interpreted with caution. LEVEL OF EVIDENCE: Level III, diagnostic study.

Entities:  

Mesh:

Year:  2017        PMID: 26883651      PMCID: PMC5289157          DOI: 10.1007/s11999-016-4738-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  26 in total

1.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.

Authors:  Suzan H M Verdegaal; Hugo F G Brouwers; Erik W van Zwet; Pancras C W Hogendoorn; Antonie H M Taminiau
Journal:  J Bone Joint Surg Am       Date:  2012-07-03       Impact factor: 5.284

3.  Surgical treatment and outcome of conventional pelvic chondrosarcoma.

Authors:  D Donati; A El Ghoneimy; F Bertoni; C Di Bella; M Mercuri
Journal:  J Bone Joint Surg Br       Date:  2005-11

Review 4.  Chondrosarcoma of the pelvis. A review of sixty-four cases.

Authors:  M E Pring; K L Weber; K K Unni; F H Sim
Journal:  J Bone Joint Surg Am       Date:  2001-11       Impact factor: 5.284

5.  How safe is curettage of low-grade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy?

Authors:  M T Brown; P D Gikas; J S Bhamra; J A Skinner; W J S Aston; R C Pollock; A Saifuddin; T W R Briggs
Journal:  Bone Joint J       Date:  2014-08       Impact factor: 5.082

6.  The diagnosis and grading of chondrosarcoma of bone: a combined cytologic and histologic approach.

Authors:  N G Sanerkin
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

7.  Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula.

Authors:  Scott D Kendell; Mark S Collins; Mark C Adkins; Murali Sundaram; Krishnan K Unni
Journal:  Skeletal Radiol       Date:  2004-06-23       Impact factor: 2.199

8.  Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones.

Authors: 
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

9.  Enchondroma versus Low-Grade Chondrosarcoma in Appendicular Skeleton: Clinical and Radiological Criteria.

Authors:  Eugenio M Ferrer-Santacreu; Eduardo J Ortiz-Cruz; José Manuel González-López; Elia Pérez Fernández
Journal:  J Oncol       Date:  2012-04-22       Impact factor: 4.375

10.  Preoperative radiographic and histopathologic evaluation of central chondrosarcoma.

Authors:  Yasuo Yoshimura; Ken-ichi Isobe; Hideki Arai; Kaoru Aoki; Munehisa Kito; Hiroyuki Kato
Journal:  Arch Orthop Trauma Surg       Date:  2013-07-03       Impact factor: 3.067

View more
  17 in total

Review 1.  F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.

Authors:  Ty K Subhawong; Aaron Winn; Shai S Shemesh; Juan Pretell-Mazzini
Journal:  Skeletal Radiol       Date:  2017-06-12       Impact factor: 2.199

2.  Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors.

Authors:  Shinji Miwa; Norio Yamamoto; Katsuhiro Hayashi; Akihiko Takeuchi; Kentaro Igarashi; Kaoru Tada; Takashi Higuchi; Hirotaka Yonezawa; Sei Morinaga; Yoshihiro Araki; Yohei Asano; Hiroko Ikeda; Takayuki Nojima; Hiroyuki Tsuchiya
Journal:  Int J Clin Oncol       Date:  2020-11-23       Impact factor: 3.402

3.  Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.

Authors:  Catharina S Lisson; Christoph G Lisson; Kerstin Flosdorf; Regine Mayer-Steinacker; Markus Schultheiss; Alexandra von Baer; Thomas F E Barth; Ambros J Beer; Matthias Baumhauer; Reinhard Meier; Meinrad Beer; Stefan A Schmidt
Journal:  Eur Radiol       Date:  2017-09-07       Impact factor: 5.315

4.  The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21st century perspective.

Authors:  A M Davies; A Patel; C Azzopardi; S L James; R Botchu; L Jeys
Journal:  J Clin Orthop Trauma       Date:  2022-07-30

Review 5.  Molecular imaging of sarcomas with FDG PET.

Authors:  Humberto Mendoza; Anton Nosov; Neeta Pandit-Taskar
Journal:  Skeletal Radiol       Date:  2022-09-29       Impact factor: 2.128

6.  Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.

Authors:  Annie Ogasawara; James R Kiefer; Herman Gill; Eugene Chiang; Shravan Sriraman; Gregory Z Ferl; James Ziai; Sandra Sanabria Bohorquez; Sebastian Guelman; Xiangdan Wang; Jihong Yang; Minh Michael Phan; Van Nguyen; Shan Chung; Christine Yu; Jeff Tinianow; Stijn Jan Hein Waaijer; Alex De Crespigny; Jan Marik; C Andrew Boswell; Tanja Zabka; Karin Staflin; Simon-Peter Williams
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-22       Impact factor: 10.057

7.  The changing face of central chondrosarcoma of bone. One UK-based orthopaedic oncology unit's experience of 33 years referrals.

Authors:  A Mark Davies; Anish Patel; Rajesh Botchu; Christine Azzopardi; Steven James; Lee Jeys
Journal:  J Clin Orthop Trauma       Date:  2021-02-27

Review 8.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

9.  Case Report: Reconstruction After Anterior Pubic Hemipelvectomy.

Authors:  Benjamin Murphy; Tharsa Thillainadesan; Kerian Robinson; Anita Clarke; Peter Choong
Journal:  Front Surg       Date:  2021-05-21

10.  Percutaneous technique for fluoroscopy-guided biopsy in the supra-acetabular region.

Authors:  Krithika Kamath; Surendra U Kamath
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.